Related Experiment Video
Updated: Dec 25, 2025
Three-Dimensional Reconstruction of Orbital Fractures
Published on: May 16, 2025
OssDsign cranioplasty in children: a single-centre experience
1Sheffield Children's Hospital, Sheffield, UK. duncanhenderson90@gmail.com.
Insights
OssDsign cranioplasty plates show promising results in pediatric patients, with zero infections and high satisfaction with cosmetic outcomes. This early study suggests potential benefits for children requiring cranial reconstruction.
Area of Science:
- Neurosurgery
- Biomaterials
Background:
- Cranioplasty is a surgical procedure to repair skull defects.
- OssDsign has developed novel cranioplasty plates using calcium phosphate reinforced with titanium.
- Limited data exists on the efficacy and safety of these plates in pediatric populations.
Purpose of the Study:
- To evaluate the cosmetic outcomes and infection rates of OssDsign cranioplasty plates in pediatric patients.
- To assess the suitability of OssDsign plates for pediatric cranial reconstruction.
Main Methods:
- A retrospective case series was conducted at a single pediatric center.
- Included all pediatric patients who underwent OssDsign cranioplasty.
- Cosmetic outcomes were subjectively assessed by parental reports.
Main Results:
- Seven pediatric patients received OssDsign cranioplasty (2 bifrontal, 5 hemicranioplasties).
- The infection rate was zero across all cases.
- Parents reported high satisfaction with the cosmetic results of OssDsign plates.
- One patient experienced cosmetic dissatisfaction with a titanium plate (not OssDsign).
Conclusions:
- Early findings suggest OssDsign cranioplasty is associated with a low infection rate in pediatric patients.
- The plates appear to yield favorable cosmetic outcomes in pediatric cranial reconstruction.
- Further research is warranted to confirm these findings in larger cohorts.
Introduction:
OssDsign have developed a new type of cranioplasty plate, consisting of calcium phosphate reinforced with titanium. Currently, there is little known about the cosmetic outcomes and infection rate when OssDsign cranioplasty plates are implanted into paediatric patients.
Methods:
A retrospective case series was performed to include all paediatric patients who received an OssDsign cranioplasty at a single centre, Sheffield Children's Hospital. The cosmetic outcomes were subjectively reported by the parents of the children.
Results:
We identified seven paediatric patients where OssDsign cranioplasty was performed. This included two bifrontal and five hemicranioplasties. However, there was failure to implant an OssDsign hemicranioplasty in one patient where a titanium plate was subsequently used. The median duration of follow-up was 15 months. The infection rate was zero. The parents of the patients who successfully received OssDsign cranioplasties were pleased with the cosmetic outcomes. There were cosmetic complaints from the parents of the one patient who received a titanium plate.
Conclusion:
Our early experience with OssDsign cranioplasty in paediatric patients indicates that it may potentially be associated with a low rate of infection and good cosmetic outcomes.
